Mitochondria and Experimental Obesity Drugs
Context:
Researchers have developed experimental drugs that target mitochondria to work harder and burn more calories
This potentially paves the way for new obesity treatments
Mitochondria:
Mitochondria are widely known as the powerhouses of the cell.
The principal role of mitochondria is the production of adenosine triphosphate (ATP), the main (chemical)energy-carrying molecule used by cells.
This process, known as cellular respiration, converts nutrients and oxygen into ATP.
The number of mitochondria within a cell varies widely, from none in mature red blood cells to over 2,000 in a liver cell, reflecting the energy demands of the specific tissue.
Structure: Mitochondrion’s structure is enclosed by two distinct membranes:
A smooth outer membrane
A folded inner membrane, called cristae.
The innermost compartment, known as the matrix, is a fluid-filled space containing enzymes and the mitochondrion’s own genetic material.
Mechanism of Mitochondrial Uncouplers:
Mitochondrial uncouplers are molecules that disrupt the ATP production process
They cause cells to burn energy less efficiently, releasing fuel as heat instead of converting it into usable energy.
Consequently, cells are triggered to consume more fats to meet their energy needs.
While these compounds were discovered a century ago, earlier versions were lethal poisons that caused fatal overheating
Mild Mitochondrial Uncouplers:
A team from the University of Technology Sydney has developed safer, mild uncouplers by precisely adjusting the chemical structure of experimental molecules
These new molecules slow the energy-burning process to a level that cells can handle, avoiding adverse effects
Apart from treating obesity, these mild uncouplers reduce oxidative stress, which could improve metabolic health
They could also provide anti-aging effects and protect against neurodegenerative diseases (like dementia).